Uncategorised - European Medical Journal

Complex High-risk Interventional Patients and Procedures: Case-based review and patient management.

We are pleased to bring you a roundtable discussion webinar exploring complex high-risk interventional procedures, including comprehensive discussion on a patient case and effective patient management strategies.

Vitiligo Is an Immune Mediated Disease – Do We Have the Right Approach and Tools to Manage?

This two-part podcast series delves into vitiligo as a systemic disease, its known risk factors, and the stigma often associated with the condition.

Interview: Maureen Kohi

Maureen Kohi – University of North Carolina (UNC) at Chapel Hill, USA. During medical school, I found myself gravitating towards…

Children with Atopic Dermatitis More Likely to Develop Other Skin Conditions

Children with atopic dermatitis are more likely to develop other skin conditions. Despite this, researchers reported that many children with AD are not referred for patch testing, and ACD is often underdiagnosed.

A patient's right to thrive, not just survive

Listen to Isabel chatting with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb.

ESMO 2023 Industry Sponsored Satellite Symposium: Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment with Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

At the 2023 European Society for Medical Oncology (ESMO) Annual Congress, held in Madrid, Spain, Jürgen Wolf, University Hospital Cologne…

VPAG: the UK's ticket to pharma superpower status?

A deal ends months of wrangling between the UK government and the ABPI, but what will it mean for the industry and the UK’s bid to become a life sciences superpower?

Poor Mental Health in Patients with Atopic Dermatitis

According to new research, the chance of developing anxiety and depression is increased in patients with atopic dermatitis, mostly when additional allergic symptoms are present.

Review of the European Society for Medical Oncology (ESMO) Congress 2023

RENOWNED for its art, history, and above all, churros, Madrid, Spain, saw thousands flock to the city this October for the European Society…

Clinical Perspectives on the Evolution of Non-small Cell Lung Cancer Treatment With Immuno-oncology and ROS1 Tyrosine Kinase Inhibitors

The non-small cell lung cancer (NSCLC) treatment landscape has rapidly evolved over the last two decades. The addition of immuno-oncology…